Our previous studies showed that CCL18 is highly expressed in NSCLC tissues and the serum of lung cancer patients, whereby its expression levels were positively correlated with a late clinical stage and lymph node metastasis of NSCLC [15]. This evidence concerns the gene CCL18 and metastatic malignant neoplasm in the lymph nodes.